INSIGHTS ON REGULATORY COMPLIANCE
-
Integrate Ops And Supply Chain To Ensure Consistent Drug Availability
To ensure consistent drug supply, pharmaceutical companies must integrate operations and supply chain management for proactive planning and global risk mitigation.
-
Gaining A Competitive Edge Through Regulatory Compliance Confidence
Achieving regulatory compliance confidence is paramount for safety and competitive advantage. Adherence to standards and robust risk mitigation are essential to avoid delays and detrimental outcomes.
-
AI In Quality: Practical Applications, Regulatory Perspectives, And Preparing QA Teams
Integrating AI into regulated workflows requires robust risk-based validation, human oversight, and data integrity to ensure compliance with evolving global regulatory frameworks.
-
NGS In GMP Manufacturing: Reducing Risk, Increasing Return
Global regulators now recognize NGS as a rigorous, GMP‑ready tool for viral safety, driving a shift toward scalable quality strategies. Learn why NGS is becoming central to modern manufacturing.
-
Compressed Gas Contamination: Guidelines For Control In Aseptic Manufacturing10/18/2024
Explore key guidelines for preserving the purity and quality of compressed gas, with an emphasis on contaminants, monitoring, and preventive maintenance practices.
-
Quality: The Link Between Platform, Processes, And Patients2/18/2025
Quality management in healthcare and life sciences is crucial for optimizing patient health. Learn how modern quality management systems optimize patient outcomes, enhance safety, and drive operational efficiency.
-
Your Environmental Monitoring Can't Be Your Only Line Of Defense9/1/2025
Environmental monitoring (EM) is essential, but it’s only part of the picture. Discover why a proactive contamination control strategy is key to keeping your cleanroom truly audit-ready.
-
Modernizing Your Way To Success In Cell And Gene Therapy Manufacturing7/24/2025
Cell and gene therapy has evolved from a niche concept to a booming sector in just five years, with over 1,300 companies and growing momentum in innovation, investment, and regulatory approvals.
-
Annex 1 FAQs: Responding To The 2022 Revision5/11/2026
Viewing the Annex 1 revision as a natural extension of current habits, rather than a burden, allowed for a seamless transition. Since contamination control was already standard, the update simply validated existing excellence.
REGULATORY COMPLIANCE SOLUTIONS
-
Automate data acquisition, monitor trends in real time, and respond to deviations proactively.
-
Ensure sterile compliance and safety by understanding proper airflow and pressure dynamics in your compounding workflow. Choose the right hardware for your facility.
-
Sterility is key for high-risk applications such as injectables, parenteral formulations, ophthalmic and peritoneal dialysis solutions, and many more.
-
The Food and Drug Administration (FDA), United States Pharmacopeia (USP) and EMA Annex 1 issue strict guidelines for testing the integrity of IV bags and containers closed by fusion. IV bag manufacturers are one among many sterile product manufacturers that must meet these test requirements for container closure integrity.
-
Accelerate cell and gene therapy programs with scalable lentiviral vector manufacturing, delivering high titers, exceptional purity, and reliable clinical supply from gene to clinic.